GlassScriptPhysician profile
Craig B Wiener
NPI 1801886148
$12,605.00
in general payments reported to CMS, 2019-2025
68 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,646 · 2020: $1,544 · 2021: $1,247 · 2022: $1,290 · 2023: $2,184 · 2024: $1,359 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,631 · Travel and Lodging: $918 · Education: $279 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,630.68 |
| Travel and Lodging | $917.77 |
| Education | $279.09 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $1,604.66 | 2019-2024 | |
| Abbvie INC. | $1,016.79 | 2019-2025 | Vraylar, Orilissa, Lo Loestrin Fe |
| Momentis Surgical INC. | $967.77 | 2022-2023 | Anovo Surgical System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $767.70 | 2019-2025 | Xifaxan, Trulance |
| Celularity INC. | $600.00 | 2020 | |
| Novo Nordisk INC | $529.69 | 2019-2025 | Wegovy |
| Pfizer INC. | $522.12 | 2019-2025 | |
| Astellas Pharma US INC | $521.82 | 2019-2025 | Veozah |
| Asensus Surgical, INC. | $473.18 | 2019 | |
| Millicent US INC | $405.18 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Allergan, INC. | $397.71 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $364.76 | 2021-2025 | |
| Hologic Sales and Service, LLC | $351.35 | 2020-2025 | Myosure Tissue Removal Device, Novasure |
| Exeltis, USA INC. | $309.79 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $223.90 | 2019-2022 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $220.76 | 2023-2025 | Myfembree, Gemtesa |
| Radius Health, INC. | $182.86 | 2019-2025 | Tymlos |
| Sage Therapeutics, LLC | $182.25 | 2024-2025 | Zurzuvae |
| Teva Pharmaceuticals USA, INC. | $175.55 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $175.26 | 2019-2025 | Trintellix |
| Medtronic, INC. | $168.40 | 2021-2022 | |
| Baxter Healthcare | $143.86 | 2023 | Tisseel |
| Amgen INC. | $139.56 | 2019-2025 | Evenity |
| Exact Sciences Corporation | $135.44 | 2023-2025 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $121.25 | 2021-2025 | Solosec, Phexx, Phexxi |
| Ibsa Pharma INC. | $119.60 | 2019-2023 | Tirosint, Licart |
| Currax Pharmaceuticals LLC | $119.02 | 2020-2025 | Contrave |
| Agile Therapeutics, INC. | $116.96 | 2021-2024 | Twirla |
| Lilly USA, LLC | $113.17 | 2019-2025 | Zepbound, Reyvow, Emgality |
| Integra Lifesciences Corporation | $89.98 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merz North America, INC. | $79.86 | 2019 | |
| Myovant Sciences INC. | $70.58 | 2022 | |
| Vivus LLC | $70.13 | 2019-2022 | |
| Lundbeck LLC | $70.00 | 2024-2025 | Vyepti |
| Avion Pharmaceuticals | $65.23 | 2019-2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $60.05 | 2021-2025 | |
| Urovant Sciences INC | $57.62 | 2022 | |
| Mission Pharmacal Company | $55.05 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $54.14 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $53.68 | 2019-2020 | |
| Duchesnay USA Incorporated | $52.96 | 2019 | |
| Convatec INC. | $44.49 | 2024 | |
| Avanos Medical | $44.48 | 2019-2021 | |
| Mimedx Group, INC. | $43.90 | 2025 | |
| Dysis Medical, INC. | $43.42 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $41.62 | 2023 | Vivjoa |
| Axonics, INC. | $40.88 | 2022-2023 | Bulkamid, Axonics |
| Supernus Pharmaceuticals, INC. | $33.96 | 2025 | Qelbree |
| Samsung Hme America, INC. | $30.00 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $28.82 | 2019 | |
| Qol Medical, LLC | $28.50 | 2021 | |
| Kerecis Limited | $28.19 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Lupin INC. | $27.88 | 2019 | |
| Channel Medsystems, INC. | $26.89 | 2022-2023 | |
| Smith+Nephew, INC. | $21.03 | 2020 | |
| Aspira Women'S Health INC | $18.07 | 2019 | |
| Optumhealth Care Solutions, LLC | $18.03 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Becton, Dickinson and Company | $16.51 | 2025 | Bd Onclarity |
| Ascend Therapeutics US, LLC | $14.97 | 2022 | |
| Shire North American Group INC | $14.16 | 2019 | |
| Vanda Pharmaceuticals INC. | $14.04 | 2025 | Fanapt |
| Bausch Health US, LLC | $13.96 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.73 | 2019 | |
| Meditrina | $12.36 | 2023 | |
| Scynexis, INC. | $11.37 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.25 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Wiener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.